1. Home
  2. IHT vs ALZN Comparison

IHT vs ALZN Comparison

Compare IHT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

HOLD

Current Price

$1.08

Market Cap

10.8M

Sector

Finance

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.00

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHT
ALZN
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
7.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
IHT
ALZN
Price
$1.08
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
11.9K
72.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.92%
N/A
EPS Growth
N/A
22.99
EPS
N/A
N/A
Revenue
$7,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.33
N/A
52 Week Low
$0.95
$0.51
52 Week High
$4.24
$8.22

Technical Indicators

Market Signals
Indicator
IHT
ALZN
Relative Strength Index (RSI) 37.64 49.40
Support Level $1.05 $1.88
Resistance Level $1.27 $2.59
Average True Range (ATR) 0.08 0.17
MACD -0.01 0.03
Stochastic Oscillator 40.63 71.13

Price Performance

Historical Comparison
IHT
ALZN

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: